INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 117 filers reported holding INTERSECT ENT INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,041,000 | +2.2% | 108,585 | -0.3% | 0.00% | 0.0% |
Q4 2021 | $2,975,000 | +1.8% | 108,909 | +1.4% | 0.00% | 0.0% |
Q3 2021 | $2,922,000 | +57.4% | 107,437 | -1.1% | 0.00% | – |
Q2 2021 | $1,856,000 | -31.9% | 108,622 | -16.8% | 0.00% | -100.0% |
Q1 2021 | $2,727,000 | -29.6% | 130,622 | -22.8% | 0.00% | 0.0% |
Q4 2020 | $3,876,000 | +36.5% | 169,280 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $2,840,000 | +19.6% | 174,162 | -0.6% | 0.00% | 0.0% |
Q2 2020 | $2,374,000 | +14.1% | 175,289 | -0.2% | 0.00% | 0.0% |
Q1 2020 | $2,081,000 | -46.4% | 175,618 | +12.5% | 0.00% | 0.0% |
Q4 2019 | $3,886,000 | +48.9% | 156,049 | +1.7% | 0.00% | 0.0% |
Q3 2019 | $2,609,000 | -27.7% | 153,411 | -3.2% | 0.00% | 0.0% |
Q2 2019 | $3,610,000 | -27.2% | 158,552 | +2.9% | 0.00% | 0.0% |
Q1 2019 | $4,956,000 | +18.5% | 154,125 | +3.9% | 0.00% | 0.0% |
Q4 2018 | $4,182,000 | +0.5% | 148,397 | +2.5% | 0.00% | 0.0% |
Q3 2018 | $4,163,000 | -20.6% | 144,802 | +3.4% | 0.00% | 0.0% |
Q2 2018 | $5,245,000 | -30.7% | 140,046 | -27.3% | 0.00% | -50.0% |
Q1 2018 | $7,569,000 | +49.7% | 192,551 | +23.4% | 0.00% | +100.0% |
Q4 2017 | $5,057,000 | -10.4% | 156,062 | -13.9% | 0.00% | -50.0% |
Q3 2017 | $5,645,000 | +9.1% | 181,252 | -2.1% | 0.00% | +100.0% |
Q2 2017 | $5,174,000 | +100.4% | 185,117 | +23.0% | 0.00% | 0.0% |
Q1 2017 | $2,582,000 | +57.1% | 150,540 | +10.8% | 0.00% | – |
Q4 2016 | $1,644,000 | +5.0% | 135,881 | +37.4% | 0.00% | – |
Q3 2016 | $1,566,000 | +30.6% | 98,890 | +6.6% | 0.00% | – |
Q2 2016 | $1,199,000 | -41.3% | 92,733 | -13.7% | 0.00% | -100.0% |
Q1 2016 | $2,041,000 | -10.6% | 107,399 | +5.9% | 0.00% | 0.0% |
Q4 2015 | $2,282,000 | -27.0% | 101,413 | -24.1% | 0.00% | 0.0% |
Q3 2015 | $3,128,000 | -10.9% | 133,700 | +9.0% | 0.00% | 0.0% |
Q2 2015 | $3,512,000 | +176.3% | 122,661 | +149.1% | 0.00% | – |
Q1 2015 | $1,271,000 | +272.7% | 49,234 | +168.4% | 0.00% | – |
Q4 2014 | $341,000 | +105.4% | 18,345 | +70.7% | 0.00% | – |
Q3 2014 | $166,000 | – | 10,749 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 238,698 | $3,781,000 | 3.74% |
PURA VIDA INVESTMENTS, LLC | 275,000 | $4,356,000 | 1.32% |
Broadfin Capital, LLC | 638,600 | $10,115,000 | 0.91% |
Aisling Capital LLC | 248,498 | $3,936,000 | 0.81% |
Bellevue Group AG | 205,325 | $3,252,000 | 0.59% |
Iguana Healthcare Management, LLC | 180,000 | $2,852,000 | 0.51% |
Rock Springs Capital Management LP | 345,000 | $5,465,000 | 0.34% |
SECTORAL ASSET MANAGEMENT INC | 168,140 | $2,663,000 | 0.26% |
FORMULA GROWTH LTD | 62,213 | $985,000 | 0.22% |
MENTA CAPITAL LLC | 111,915 | $1,773,000 | 0.17% |